Skip to main content
SpringerLink
Log in

Opportunistic Infections in the Brain in Developing Countries

  • Chapter
  • First Online:
HIV and the Brain

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

It is clear that HIV disease is essentially the same in any country, although the course of HIV-2 disease – seen in some places of Africa – appears to be associated with a slower disease progression and to be less severe than HIV-1 disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239(4840):586–92.

    PubMed  CAS  Google Scholar 

  2. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62(4):475–95.

    PubMed  CAS  Google Scholar 

  3. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983;14(4):403–18.

    PubMed  CAS  Google Scholar 

  4. Gray F, Gherardi R, Scaravilli F. The neuropathology of the acquired immune deficiency syndrome (AIDS). A review. Brain 1988;111 (Pt 2):245–66.

    PubMed  Google Scholar 

  5. Trachtenberg JD, Kambugu AD, McKellar M, Semitala F, Mayanja-Kizza H, Samore MH, et al. The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. Int J Infect Dis 2007;11(6):524–30.

    PubMed  Google Scholar 

  6. Lubic LG, Marotta JT. Brain tumor and lumbar puncture. AMA Arch Neurol Psychiatry 1954;72(5):568–72.

    PubMed  CAS  Google Scholar 

  7. Evans RW. Complications of lumbar puncture. Neurol Clin 1998;16(1):83–105.

    PubMed  CAS  Google Scholar 

  8. Roos K. Cerebrospinal fluid. In: Roos K, editor. Principles of Neurologic Infectious Diseases. New York: McGraw-Hill; 2005. p. 1–12.

    Google Scholar 

  9. Cahn P, Belloso WH, Murillo J, Prada-Trujillo G. AIDS in Latin America. Infect Dis Clin North Am 2000;14(1):185–209.

    PubMed  CAS  Google Scholar 

  10. Sharif M, Ziaei H, Daryani A, Ajami A. Seroepidemiological study of toxoplasmosis in intellectual disability children in rehabilitation centers of northern Iran. Res Dev Disabil 2007;28(3):219–24.

    PubMed  CAS  Google Scholar 

  11. Yazar S, Eser B, Yay M. Prevalence of anti-toxoplasma Gondii antibodies in Turkish blood donors. Ethiop Med J 2006;44(3):257–61.

    PubMed  Google Scholar 

  12. Chen XG, Wu K, Lun ZR. Toxoplasmosis researches in China. Chin Med J (Engl) 2005;118(12):1015–21.

    Google Scholar 

  13. Song KJ, Shin JC, Shin HJ, Nam HW. Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol 2005;43(2):69–71.

    PubMed  Google Scholar 

  14. Fan CK, Hung CC, Su KE, Sung FC, Chiou HY, Gil V, et al. Seroprevalence of Toxoplasma gondii infection among pre-schoolchildren aged 1–5 years in the Democratic Republic of Sao Tome and Principe, Western Africa. Trans R Soc Trop Med Hyg 2006;100(5):446–9.

    PubMed  Google Scholar 

  15. Fachado A, Fonte L, Alberti E, Hadad P, Fonseca L, Machin R, et al. Usefulness of the detection of Toxoplasma gondii antigens in AIDS patients. Rev Inst Med Trop Sao Paulo 1994;36(6):525–9.

    PubMed  CAS  Google Scholar 

  16. Silva F, Torres A, Prada G. Encefalitis por toxoplasma y SIDA: Análisis de 27 episodios. Rev Panam Infectol 1997;1(1):4–9.

    Google Scholar 

  17. Lindstrom I, Kaddu-Mulindwa DH, Kironde F, Lindh J. Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patients from Uganda. Acta Trop 2006;100(3):218–22.

    PubMed  Google Scholar 

  18. Uneke CJ, Duhlinska DD, Njoku MO, Ngwu BA. Seroprevalence of acquired toxoplasmosis in HIV-infected and apparently healthy individuals in Jos, Nigeria. Parassitologia 2005;47(2):233–6.

    PubMed  CAS  Google Scholar 

  19. Simpore J, Savadogo A, Ilboudo D, Nadambega MC, Esposito M, Yara J, et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol 2006;78(6):730–3.

    PubMed  Google Scholar 

  20. Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. Int J STD AIDS 2005;16(4):302–6.

    PubMed  CAS  Google Scholar 

  21. Silva MT, Araujo A. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil. J Neurovirol 2005;11 Suppl 3:11–5.

    PubMed  Google Scholar 

  22. Tadesse T, Langford D, Manji K, Mehari E. Patterns of neuroAIDS in Africa. J Neurovirol 2005;11 Suppl 1:22–6.

    PubMed  Google Scholar 

  23. Mohar A, Romo J, Salido F, Jessurun J, Ponce de Leon S, Reyes E, et al. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 1992;6(5):467–73.

    PubMed  CAS  Google Scholar 

  24. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N’Gbichi JM, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993;7(12):1569–79.

    PubMed  CAS  Google Scholar 

  25. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989–96). Indian J Med Res 2000;111:14–23.

    PubMed  CAS  Google Scholar 

  26. Bell JE, Lowrie S, Koffi K, Honde M, Andoh J, De Cock KM, et al. The neuropathology of HIV-infected African children in Abidjan, Cote d’Ivoire. J Neuropathol Exp Neurol 1997;56(6):686–92.

    PubMed  CAS  Google Scholar 

  27. Vidal JE, Hernandez AV, de Oliveira AC, Dauar RF, Barbosa SP, Jr., Focaccia R. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDS 2005;19(10):626–34.

    PubMed  Google Scholar 

  28. Walker M, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 2005;40(7):1005–15.

    PubMed  Google Scholar 

  29. Modi M, Mochan A, Modi G. Management of HIV-associated focal brain lesions in developing countries. Qjm 2004;97(7):413–21.

    PubMed  CAS  Google Scholar 

  30. Shankar SK, Mahadevan A, Satishchandra P, Kumar RU, Yasha TC, Santosh V, et al. Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Med Res 2005;121(4):468–88.

    PubMed  CAS  Google Scholar 

  31. White AC, Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997;24(2):101–13; quiz 114–5.

    PubMed  Google Scholar 

  32. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med 1985;145(3):442–5.

    PubMed  CAS  Google Scholar 

  33. Soto Hernandez JL, Ostrosky Zeichner L, Tavera G, Gomez Avina A. Neurocysticercosis and HIV infection: report of two cases and review. Surg Neurol 1996;45(1):57–61.

    PubMed  CAS  Google Scholar 

  34. Thornton CA, Houston S, Latif AS. Neurocysticercosis and human immunodeficiency virus infection. A possible association. Arch Neurol 1992;49(9):963–5.

    PubMed  CAS  Google Scholar 

  35. Mauad T, Battlehner CN, Bedrikow CL, Capelozzi VL, Saldiva PH. Case report: massive cardiopulmonary cysticercosis in a leukemic patient. Pathol Res Pract 1997;193(7):527–9.

    PubMed  CAS  Google Scholar 

  36. Serpa JA, Moran A, Goodman JC, Giordano TP, White AC, Jr. Neurocysticercosis in the HIV era: a case report and review of the literature. Am J Trop Med Hyg 2007;77(1):113–7.

    PubMed  Google Scholar 

  37. Kumar GR. Diagnostic criteria for neurocysticercosis: some modifications are needed for Indian patients. Neurol India 2004;52(2):171–77.

    Google Scholar 

  38. Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand 1997;96(2):76–81.

    PubMed  CAS  Google Scholar 

  39. Harms G, Feldmeier H. The impact of HIV infection on tropical diseases. Infect Dis Clin North Am 2005;19(1):121–35, ix.

    PubMed  Google Scholar 

  40. Simooya OO, Mwendapole RM, Siziya S, Fleming AF. Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia. BMJ 1988;297(6640):30–1.

    PubMed  CAS  Google Scholar 

  41. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 2004;18(3):547–54.

    PubMed  Google Scholar 

  42. Francesconi P, Fabiani M, Dente MG, Lukwiya M, Okwey R, Ouma J, et al. HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS 2001;15(18):2445–50.

    PubMed  CAS  Google Scholar 

  43. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001;15(7):899–906.

    PubMed  CAS  Google Scholar 

  44. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000;356(9235):1051–6.

    PubMed  CAS  Google Scholar 

  45. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005;365(9455):233–40.

    PubMed  Google Scholar 

  46. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94 Suppl 1:S1–90.

    Google Scholar 

  47. Schmutzhard E. Protozoal infections. In: Roos K, editor. Principles of Neurologic Infectious Diseases. New York: McGraw-Hill; 2001. pp. 265–306.

    Google Scholar 

  48. Malaria. In: Brasil MdSd, editor. Guia de Vigilância Epidemiológica. Brasília: Ministério da Saúde; 2005. p. 521–40.

    Google Scholar 

  49. Chagas’ disease: frequency and geographical distribution. Wkly Epidemiol Rec 1990;65:257–64.

    Google Scholar 

  50. Prata A. Chagas’ disease. Infect Dis Clin North Am 1994;8(1):61–76.

    PubMed  CAS  Google Scholar 

  51. Jardim E, Takayanagui OM. Chagasic meningoencephalitis with detection of Trypanossoma cruzi in the cerebrospinal fluid of an immunodepressed patient. J Trop Med Hyg 1994;97:367–70.

    PubMed  CAS  Google Scholar 

  52. Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: HUMAN immunodeficiency virus co-infection. Rev Soc Bras Med Trop 2006;39(4):392–415.

    Google Scholar 

  53. Lazo J, Meneses AC, Rocha A, Ferreira MS, Marquez JO, Chapadeiro E, et al. Chagasic meningoencephalitis in the immunodeficient. Arq Neuropsiquiatr 1998;56(1):93–7.

    PubMed  CAS  Google Scholar 

  54. Rocha A, Ferreira MS, Nishioka SA, Silva AM, Burgarelli MK, Silva M, et al. Trypanosoma cruzi meningoencephalitis and myocarditis in a patient with acquired immunodeficiency syndrome. Rev Inst Med Trop Sao Paulo 1993;35(2):205–8.

    PubMed  CAS  Google Scholar 

  55. Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007;7(4):266–81.

    PubMed  CAS  Google Scholar 

  56. de Silva T, Raychaudhuri M, Poulton M. HIV infection associated with Strongyloides stercoralis colitis resulting in Streptococcus bovis bacteraemia and meningitis. Sex Transm Infect 2005;81:276–277.

    PubMed  CAS  Google Scholar 

  57. Morgello S, Soifer FM, Lin CS, Wolfe DE. Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol (Berl) 1993;86(3):285–8.

    CAS  Google Scholar 

  58. Dutcher JP, Marcus SL, Tanowitz HB, Wittner M, Fuks JZ, Wiernik PH. Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma. Cancer 1990;66(11):2417–20.

    PubMed  CAS  Google Scholar 

  59. Brown M, Cartledge JD, Miller RF. Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapy. Int J STD AIDS 2006;17(8):560–1.

    PubMed  CAS  Google Scholar 

  60. Leishmaniasis. Geneva: World Health Organization 2005.

    Google Scholar 

  61. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997;10(2):298–319.

    PubMed  CAS  Google Scholar 

  62. Hashim FA, Ahmed AE, el Hassan M, el Mubarak MH, Yagi H, Ibrahim EN, et al. Neurologic changes in visceral leishmaniasis. Am J Trop Med Hyg 1995;52(2):149–54.

    PubMed  CAS  Google Scholar 

  63. Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 2006;42(1):115–25.

    PubMed  Google Scholar 

  64. Prasad LS, Sen S. Migration of Leishmania donovani amastigotes in the cerebrospinal fluid. Am J Trop Med Hyg 1996;55(6):652–4.

    PubMed  CAS  Google Scholar 

  65. Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the Third World. Med Mycol 2000;38 Suppl 1:269–79.

    PubMed  Google Scholar 

  66. Darze C, Lucena R, Gomes I, Melo A. The clinical laboratory characteristics of 104 cases of cryptococcal meningoencephalitis. Rev Soc Bras Med Trop 2000;33(1):21–6.

    PubMed  CAS  Google Scholar 

  67. Molez JF. The historical question of acquired immunodeficiency syndrome in the 1960s in the Congo River basin area in relation to cryptococcal meningitis. Am J Trop Med Hyg 1998;58(3):273–6.

    PubMed  CAS  Google Scholar 

  68. Desmet P, Kayembe KD, De Vroey C. The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire. AIDS 1989;3(2):77–8.

    PubMed  CAS  Google Scholar 

  69. Liechty CA, Solberg P, Were W, Ekwaru JP, Ransom RL, Weidle PJ, et al. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health 2007;12(8):929–35.

    PubMed  Google Scholar 

  70. Woods ML, 2nd, MacGinley R, Eisen DP, Allworth AM. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 1998;12(12):1491–4.

    PubMed  CAS  Google Scholar 

  71. Robertson K, Kopnisky K, Mielke J, Appiah K, Hall C, Price R, et al. Assessment of neuroAIDS in Africa. J Neurovirol 2005;11 Suppl 1:7–16.

    PubMed  Google Scholar 

  72. Okongo M, Morgan D, Mayanja B, Ross A, Whitworth J. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol 1998;27(4):698–702.

    PubMed  CAS  Google Scholar 

  73. Bellamy R, Sangeetha S, Paton NI. Causes of death among patients with HIV in Singapore from 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS). HIV Med 2004;5(4):289–95.

    PubMed  CAS  Google Scholar 

  74. Brew B. Cryptococcal meningitis. In: Brew B, editor. HIV Neurology. New York: Oxford University Press; 2001. p. 91–95.

    Google Scholar 

  75. Heyderman RS, Gangaidzo IT, Hakim JG, Mielke J, Taziwa A, Musvaire P, et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 1998;26(2):284–9.

    PubMed  CAS  Google Scholar 

  76. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992;326(2):83–9.

    PubMed  CAS  Google Scholar 

  77. Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med 1990;113(3):183–7.

    PubMed  CAS  Google Scholar 

  78. Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis 2006;43(8):1069–73.

    PubMed  CAS  Google Scholar 

  79. Hamill R. Free fluconazole for Cryptococcal Meningitis:too little of a good thing? Clin Infect Dis 2006;43:1074–76.

    PubMed  Google Scholar 

  80. Wanke B, Londero A. Epidemiology and paracoccidioidomycosis infection. In: Franco M, Lacaz C, Restrepo-Moreno A, Del Negro G, editors. Paracoccidiodomycosis. Boca Raton: CRC Press; 1994. p. 109–17.

    Google Scholar 

  81. Paniago AM, de Freitas AC, Aguiar ES, Aguiar JI, da Cunha RV, Castro AR, et al. Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil. J Infect 2005;51(3):248–52.

    PubMed  Google Scholar 

  82. Sugar AM, Restrepo A, Stevens DA. Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis 1984;129(2):340–2.

    PubMed  CAS  Google Scholar 

  83. Pla MP, Hartung C, Mendoza P, Stukanoff A, Moreno MJ. Neuroparacoccidioidomycosis: case reports and review. Mycopathologia 1994;127(3):139–44.

    PubMed  CAS  Google Scholar 

  84. Fagundes-Pereyra WJ, Carvalho GT, de Miranda Goes A, das Chagas Lima e Silva F, de Sousa AA. [Central nervous system paracoccidioidomycosis: analysis of 13 cases]. Arq Neuropsiquiatr 2006;64(2A):269–76.

    PubMed  Google Scholar 

  85. Duarte R, Maia A, Duarte J, Furtado C. Paracoccidioidomicose cerebral: relato de um caso e revisão da literatura. Res Pes Med 1997;31:37–41.

    Google Scholar 

  86. Raphael A. Localização nervosa da blastomicose sul-americana. Ver Hosp Clin (São Paulo) 1966;24:69–90.

    Google Scholar 

  87. Goldani LZ, Sugar AM. Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis 1995;21(5):1275–81.

    PubMed  CAS  Google Scholar 

  88. Leimann B, Pizzini C, Muniz M, Albuquerque P, Monteiro P, Reis R, et al. Histoplasmosis in a Brazilian center:clinical forms and laboratory tests. Rev Iberoam Micol 2005;22:141–46.

    PubMed  Google Scholar 

  89. Lewden C, Sobesky M, Cabie A, Couppie P, Boulard F, Bissuel F. Causes of death among HIV-infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART). Med Mal Infect 2004;34:286–92.

    PubMed  CAS  Google Scholar 

  90. Hay RJ, White HS, Fields PE, Quamina DB, Dan M, Jones TR. Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection. J Trop Med Hyg 1981;84(1):9–12.

    PubMed  CAS  Google Scholar 

  91. Bullock W. Histoplasma capsulatum. In: Mandell G, Douglas J, Dolin R, editors. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone; 1995. pp. 2340–53.

    Google Scholar 

  92. Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis Clin North Am 2003;17(1):1–19, vii.

    PubMed  Google Scholar 

  93. Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 1990;69(4):244–60.

    CAS  Google Scholar 

  94. de Francesco Daher E, de Sousa Barros FA, da Silva Junior GB, Takeda CF, Mota RM, Ferreira MT, et al. Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis. Am J Trop Med Hyg 2006;74(4):600–3.

    PubMed  Google Scholar 

  95. Couppie P, Aznar C, Carme B, Nacher M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis 2006;19(5):443–9.

    PubMed  Google Scholar 

  96. Leimann BC, Pizzini CV, Muniz MM, Albuquerque PC, Monteiro PC, Reis RS, et al. Histoplasmosis in a Brazilian center: clinical forms and laboratory tests. Rev Iberoam Micol 2005;22(3):141–6.

    PubMed  Google Scholar 

  97. Crump JA, Corder JR, Henshaw NG, Reller LB. Development, implementation, and impact of acceptability criteria for serologic tests for infectious diseases. J Clin Microbiol 2004;42(2):881–3.

    PubMed  Google Scholar 

  98. Rocha MM, Dassin T, Lira R, Lima EL, Severo LC, Londero AT. Sporotrichosis in patient with AIDS: report of a case and review. Rev Iberoam Micol 2001;18(3):133–6.

    PubMed  CAS  Google Scholar 

  99. Donabedian H, O’Donnell E, Olszewski C, MacArthur RD, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis 1994;18(2):111–5.

    PubMed  CAS  Google Scholar 

  100. Heller HM, Fuhrer J. Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS 1991;5(10):1243–6.

    PubMed  CAS  Google Scholar 

  101. Silva-Vergara ML, Maneira FR, De Oliveira RM, Santos CT, Etchebehere RM, Adad SJ. Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol 2005;43(2):187–90.

    PubMed  Google Scholar 

  102. Hardman S, Stephenson I, Jenkins DR, Wiselka MJ, Johnson EM. Disseminated Sporothix schenckii in a patient with AIDS. J Infect 2005;51(3):e73–7.

    PubMed  CAS  Google Scholar 

  103. Muniyandi M, Ramachandran R, Gopi PG, Chandrasekaran V, Subramani R, Sadacharam K, et al. The prevalence of tuberculosis in different economic strata: a community survey from South India. Int J Tuberc Lung Dis 2007;11(9):1042–5.

    PubMed  CAS  Google Scholar 

  104. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163(9):1009–21.

    PubMed  Google Scholar 

  105. Thwaites GE, Lan NT, Dung NH, Quy HT, Oanh DT, Thoa NT, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005;192(1):79–88.

    PubMed  Google Scholar 

  106. Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1991;22(7):700–10.

    PubMed  CAS  Google Scholar 

  107. Lanjewar DN, Jain PP, Shetty CR. Profile of central nervous system pathology in patients with AIDS: an autopsy study from India. AIDS 1998;12(3):309–13.

    PubMed  CAS  Google Scholar 

  108. Oliveira JF, Greco DB, Oliveira GC, Christo PP, Guimaraes MD, Oliveira RC. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop 2006;39(2):146–51.

    PubMed  Google Scholar 

  109. Brew B. Tuberculous meningitis. In: Brew B, editor. HIV Neurology. New York: Oxford University Press; 2001. pp. 97–99.

    Google Scholar 

  110. Garcia-Monco J. CNS Tuberculosis and Mycobacteriosis. In: Roos K, editor. Principles of Neurologic Infectious Diseases. New York: McGraw-Hill; 2005. pp. 195–214.

    Google Scholar 

  111. Bernaerts A, Vanhoenacker FM, Parizel PM, Van Goethem JW, Van Altena R, Laridon A, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003;13(8):1876–90.

    PubMed  CAS  Google Scholar 

  112. Puccioni-Sohler M, Brandao CO. Factors associated to the positive cerebrospinal fluid culture in the tuberculous meningitis. Arq Neuropsiquiatr 2007;65(1):48–53.

    PubMed  Google Scholar 

  113. Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol 2005;4(3):160–70.

    PubMed  Google Scholar 

  114. Machado LR, Livramento JA, Bydlowski SP, Bendit I, Bravo LM, Spina-Franca A. Polymerase chain reaction in the diagnosis of tuberculous meningitis. Preliminary report. Arq Neuropsiquiatr 1994;52(3):445–6.

    PubMed  CAS  Google Scholar 

  115. Machado LD, Livramento JA, Spina-Franca A. [Adenosine deaminase in the cerebrospinal fluid of patients with acquired immunodeficiency syndrome]. Arq Neuropsiquiatr 1995;53(4):755–9.

    PubMed  CAS  Google Scholar 

  116. Berger JR, Kaszovitz B, Post MJ, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 1987;107(1):78–87.

    PubMed  CAS  Google Scholar 

  117. von Giesen HJ, Neuen-Jacob E, Dorries K, Jablonowski H, Roick H, Arendt G. Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. J Neurol Sci 1997;147(1):63–72.

    PubMed  CAS  Google Scholar 

  118. Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003;9 Suppl 1:47–53.

    PubMed  CAS  Google Scholar 

  119. Fink MC, Penalva de Oliveira AC, Milagres FA, Vidal JE, Picerno-Pouza AF, Duarte Neto A, et al. JC virus DNA in cerebrospinal fluid samples from Brazilian AIDS patients with focal brain lesions without mass effect. J Infect 2006;52(1):30–6.

    PubMed  CAS  Google Scholar 

  120. Berger JR. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol 2003;9 Suppl 1:38–41.

    PubMed  CAS  Google Scholar 

  121. Agostini HT, Brubaker GR, Shao J, Levin A, Ryschkewitsch CF, Blattner WA, et al. BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania. Arch Virol 1995;140(11):1919–34.

    PubMed  CAS  Google Scholar 

  122. Shankar SK, Satishchandra P, Mahadevan A, Yasha TC, Nagaraja D, Taly AB, et al. Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation? J Neurovirol 2003;9 Suppl 1:59–67.

    PubMed  CAS  Google Scholar 

  123. Chima SC, Agostini HT, Ryschkewitsch CF, Lucas SB, Stoner GL. Progressive multifocal leukoencephalopathy and JC virus genotypes in West African patients with acquired immunodeficiency syndrome: a pathologic and DNA sequence analysis of 4 cases. Arch Pathol Lab Med 1999;123(5):395–403.

    PubMed  CAS  Google Scholar 

  124. Agostini HT, Yanagihara R, Davis V, Ryschkewitsch CF, Stoner GL. Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration. Proc Natl Acad Sci U S A 1997;94(26):14542–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Clinical Research Laboratory on Neuroinfection, Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation (FIOCRUZ), Avenida Brasil 4365, Rio de Janeiro, Brasil

    Marcus Tulius, T. Silva & Beatriz Grinsztejn

Authors
  1. Marcus Tulius
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beatriz Grinsztejn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Silva .

Editor information

Editors and Affiliations

  1. Department of Psychology Behavioral Neuroscience, University of Missouri – St. Louis, St. Louis, U.S.A.

    Robert H. Paul PhD

  2. Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, MD, U.S.A.

    Ned Charlton Sacktor

  3. Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, U.S.A.

    Victor Valcour

  4. Memory and Aging Center Department of Neurology, UCSF, San Francisco, CA, U.S.A.

    Victor Valcour

  5. The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI, U.S.A.

    Karen Tokie Tashima

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Tulius, M., Silva, T., Grinsztejn, B. (2009). Opportunistic Infections in the Brain in Developing Countries. In: Paul, R., Sacktor, N., Valcour, V., Tashima, K. (eds) HIV and the Brain. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-434-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-434-6_14

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-934115-08-4

  • Online ISBN: 978-1-59745-434-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation